Weiss Multi-Strategy Advisers’s Albireo Pharma Inc ALBO Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio ALBO Stock Details ALBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-35,322	Closed	-$763K	–	783
2022 Q4	$763K	Buy	35,322 +322	+0.9%	+$6.8K	0.02%	486
2022 Q3	$678K	Buy	+35,000	New	+$724K	0.02%	532
2022 Q1	–	Sell	-8,961	Closed	-$209K	–	827
2021 Q4	$209K	Sell	8,961 -152	-2%	-$4.04K	﹤0.01%	609
2021 Q3	$284K	Sell	9,113 -4,867	-35%	-$151K	0.01%	610
2021 Q2	$492K	Buy	13,980 +499	+4%	+$16.2K	0.01%	552
2021 Q1	$475K	Sell	13,481 -551	-4%	-$20.3K	0.01%	547
2020 Q4	$526K	Sell	14,032 -968	-6%	-$35.2K	0.01%	556
2020 Q3	$501K	Sell	15,000 -25,000	-63%	-$728K	0.01%	478
2020 Q2	$1.06M	Sell	40,000 -3,337	-8%	-$78.7K	0.03%	400
2020 Q1	$709K	Buy	43,337 +6,337	+17%	+$139K	0.03%	326
2019 Q4	$941K	Buy	37,000 +2,000	+6%	+$40K	0.02%	495
2019 Q3	$700K	Hold	35,000	–	–	0.01%	469
2019 Q2	$1.13M	Sell	35,000 -25,000	-42%	-$836K	0.03%	368
2019 Q1	$1.93M	Hold	60,000	–	–	0.05%	330
2018 Q4	$1.47M	Buy	60,000 +5,067	+9%	+$134K	0.06%	254
2018 Q3	$1.81M	Sell	54,933 -67	-0.1%	-$2.19K	0.05%	336
2018 Q2	$1.95M	Buy	55,000 +20,000	+57%	+$648K	0.05%	349
2018 Q1	$1.14M	Buy	+35,000	New	+$1.18M	0.04%	402

Other funds holding ALBO

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Weiss Multi-Strategy Advisers's ALBO Position: Q1 2023 in Review

Weiss Multi-Strategy Advisers sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 35,322 shares — an estimated $763K sold.

Weiss Multi-Strategy Advisers first reported a position in ALBO in Q1 2018 and held it in 18 quarters. The position peaked at $1.95M in Q2 2018. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

Weiss Multi-Strategy Advisers reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 35,322 Albireo Pharma Inc shares in Q1 2023, an estimated $763K.
Weiss Multi-Strategy Advisers first reported a position in Albireo Pharma Inc in Q1 2018 and held it in 18 quarters.
Weiss Multi-Strategy Advisers's Albireo Pharma Inc position peaked at $1.95M in Q2 2018.
3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2023, filed 15 May 2023.